Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Pharmacovigilance Market from 2024 to 2025?

In recent times, there has been a significant expansion in the size of the pharmacovigilance market. The projected growth sees it rising from $8.58 billion in 2024 to an astounding $9.73 billion in 2025, fueled by a compound annual growth rate (CAGR) of 13.5%. Several factors have contributed to this growth during the historic period, including an increase in the incidents of adverse drug reactions (ADRs), enhanced research and development (R&D) activities, escalated drug development rates, an amplified emphasis on personalized medicine, and the escalating incidence of chronic diseases.

What Is the Projected Market Size of the Pharmacovigilance Market?

In the coming years, the pharmacovigilance market size is predicted to witness significant expansion, reaching $15.83 billion by 2029 with a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period can be ascribed to factors such as escalating healthcare costs, augmented government aid, and an aging demographic. The forecast period will also observe major trends like increased investments, the application of artificial intelligence, the utilization of novel platforms and innovative cloud-based systems, as well as strategic mergers and acquisitions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Who are the Major Competitors in the Pharmacovigilance Market Outlook?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

What Is Fueling Growth in the Pharmacovigilance Market?

The surge in research and development activities is a major factor fuelling the growth of the pharmacovigilance market. By putting funds into R&D, companies in the pharmaceutical industry have the capacity to produce novel, innovative drugs with enhanced safety profiles. Thorough preclinical and clinical trials during the drug development phase allow for early recognition of potential safety issues, enabling relevant risk mitigation strategies. Moreover, R&D initiatives contribute to the progression of technologies for monitoring adverse events, data evaluation, and signal detection, assisting in the early identification of negative drug reactions during the post-marketing phase. For example, the Llywodraeth Cymru Welsh Government, a governmental agency based in the UK, announced in February 2024 that Wales allocated £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD) in 2022, equating to 1.9% of the total UK spending in this sector. Thus, escalating research and development activities have strongly backed the expansion of the pharmacovigilance market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Which Pharmacovigilance Market Segments Are Growing the Fastest?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Which Industry Trends Are Shaping the Future of the Pharmacovigilance Market?

Firms operating in the pharmacovigilance market are progressively leveraging artificial intelligence (AI) to enhance functional efficiency. AI can significantly improve the precision and efficiency of pharmacovigilance operations, ultimately improving patient results. By implementing AI, pharmaceutical corporations can streamline their workflows, enhance data management, accelerate drug innovations, and concurrently decrease expenses while enhancing safety measures. For instance, in August 2024, the Indian Government unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, announced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software aids in gathering and scrutinizing adverse incidents related to drugs and medical equipment, simplifying the reporting process for consumers and healthcare experts. This initiative considerably reinforces India’s pharmacovigilance framework by guaranteeing a more inclusive grasp of safety data and promoting drug safety monitoring. The ADRMS aspires to augment the efficacy of drug safety oversight and adherence to standards, aiding India’s ambition to spearhead the global pharmaceutical sector.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Which Countries Are Leading the Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

This Report Delivers Insight On:

1. How big is the pharmacovigilance market, and how is it changing globally?

2. Who are the major companies in the pharmacovigilance market, and how are they performing?

3. What are the key opportunities and risks in the pharmacovigilance market right now?

4. Which products or customer segments are growing the most in the pharmacovigilance market?

5. What factors are helping or slowing down the growth of the pharmacovigilance market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model